Intervention for Human Papillomavirus Vaccine Acceptance in Mexican Mothers (NCT06854354) | Clinical Trial Compass
CompletedNot Applicable
Intervention for Human Papillomavirus Vaccine Acceptance in Mexican Mothers
Mexico10 participantsStarted 2021-12-07
Plain-language summary
Randomized clinical trial with two groups, with a test-retest model, with single-blind approach, using a probabilistic sampling and the population was mothers of girls aged 9 to 12 years from a public elementary school in the state of Puebla. The objective was to determine the effect of the intervention "Vaccine for HPV Prevention" aimed at the acceptance of the HPV vaccine in mothers of girls aged 9 to 12 years old in the urban area of the State of Puebla.
Who can participate
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Women from 20 to 59 years old.
* Mothers of girls from 9 to 11 years old.
* Who agree to participate in the study.
* Who know how to read and write.
* Who have an electronic device (cell phone, tablet or computer).
* That they have access to social networks such as WhatsApp and Facebook.
* That they have an internet connection.
Exclusion Criteria:
* Mothers with a history of CACU and/or HPV infection in themselves or a family member.
* Mothers who have received information about CACU, HPV and/or the HPV vaccine at least one month prior to the educational intervention.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
knowledge of HPV
Timeframe: 3 months
2
Positive and negative beliefs about HPV and the vaccine
Timeframe: 3 months
3
Acceptance of the human papillomavirus vaccine
Timeframe: 3 months
Trial details
NCT IDNCT06854354
SponsorHospital Univeristario Benemerita Universidad Autonoma de Puebla